Solabia Group announced on February 19, 2026, that it had entered into an agreement to acquire Mibelle Biochmistry from Spanish multinational home and personal care company Persán S.A.. The transaction comes less than a year after Persán’s acquisition of Mibelle Group.
Founded in 1991 in Switzerland, Mibelle Biochemistry has gained global recognition for its innovative expertise in biotechnology-based ingredients for personal care applications. The company is pioneering in plant stem cell technology through its PhytoCellTec™ line and SenoCellTec™ technology launched in November 2025, targeting advanced skin regeneration.
Solabia Group, established in 1972 in France, is a raw material manufacturer serving the personal care, pharmaceutical, nutraceutical industries. As a global leader in biotechnology and plant-derived active solutions, Solabia will strengthen their position in natural and high-performance ingredients by merging two science-driven organizations with deep expertise in biotechnology, plant-based innovation, and sustainable development.
The biotechnology actives market is estimated to have exceeded $800 million in 2025, with a CAGR of 3.9%, with Europe leading with 30% market share and a forecast growth of 4.2% over the coming five years. A context in which this announcement further highlights the ongoing shifts in the competitive landscape for personal care ingredients, where companies continue to show strong interest in acquisitions to enhance innovation capabilities, technical expertise, and global reach.
Kline + Company has been tracking the personal care ingredients market through its flagship program ‘Global Personal Care Ingredients’ along with the specialty actives markets for over 30 years. Contact our expert teams if you are interested in assessing the impact of Mibelle Biochemistry’s acquisition or other developments in the personal care industry.
